Indian Pacing Electrophysiol. J.
Indian Pacing Electrophysiol. J. 2011;
Autonomic Denervation for the Treatment of Atrial Fibrillation
Download PDF 261 KBDemosthenes G. Katritsis, MD, PhD, FRCP
Department of Cardiology, Athens Euroclinic, Athens, Greece
Address for Correspondence: Dr D. Katritsis, Athens Euroclinic, 9 Athanassiadou Street, Athens 11521, Greece. E-mail: dgkatr/at/otenet.gr
The influence of the autonomic nervous system (ANS) on triggering and perpetuation of atrial fibrillation (AF) is well established. Ganglionated plexi (GP) ablation achieves autonomic denervation by affecting both the parasympathetic and sympathetic components of the ANS. An anatomic approach for GP ablation at relevant atrial sites appears to be safe, and improves the results of PV isolation in patients with paroxysmal and persistent AF. GP ablation can be accomplished endocardially or epicardially, ie, during the maze procedure or thoracoscopic approaches. Further experience is needed to assess the clinical value of this promising technique.
Keywords: atrial fibrillation, ablation, ganglionated plexi, autonomic nervous system
The influence of the autonomic nervous system (ANS) on the triggering and perpetuation of atrial fibrillation (AF) is well established. Variations of the autonomic tone have been associated with paroxysms of AF and both sympathetic and parasympathetic activation may be proarrhythmic by shortening of atrial refractoriness.[1-3] Vagal reflexes from clusters of autonomic ganglia, so-called ganglionated plexi (GP), at sites around the circumference of the left atrial-pulmonary vein (PV) junction (Figure 1), may induce and perpetuate AF through spatial heterogeneity of refractoriness.[1,4] In clinical practice, inadverted parasympathetic denervation has been proposed as a potential mechanism of circumferential or antral PV ablation for the treatment of atrial fibrillation.[5,6] Initial studies on partial vagal denervation via epicardial fat pad ablation indicated that such a dedicated approach may prevent AF,[7,8] although results have not been consistent.[9-11] Ablation of areas with prominent sympathetic innervation has also prevented sympathetic AF. The ligament of Marshall is a left atrial epicardial neuromuscular bundle, rich in sympathetic innervation, that has been associated with the genesis of atrial tachyarrhymias and AF.[12-15] Epicardial ablation of the ligament of Marshall in the canine can terminate spontaneous atrial activity and prevent AF, whereas in the human epicardial (through the coronary sinus) or endocardial [14,15] ablation at the insertion site of the Marshall bundle may terminate AF. We know now that selective parasympathetic or sympathetic denervation may not be feasible. Both sympathetic and parasympathetic elements reside in all four major left atrial ganglionated plexi,[16,17] and ablation lesions may unavoidably affect both components of the autonomic nervous system. The area around the ligament of Marshall that has been previously thought to represent an area of predominantly sympathetic innervation has been shown to contain parasympathertic fibers as well. Thus, although initial studies on GP ablation were characterized as attempts at specific parasympathetic denervation, this may not be true. Actually, ablation of atrial areas containing GP unavoidably results in autonomic denervation.
Figure 1. Anatomic position of the major GP targeted for catheter ablation. Presumed GP clusters are ablated 1-2 cm outside the PV-LA junctions at the following sites: left superolateral area (superior left GP-SLGP), right superoanterior area (anterior right GP-ARGP), left inferoposterior area (inferior left GP-ILGP), and right inferoposterior area (inferior right GP-IRGP). Another GP (crux GP) the inferoposterior area between the ILGP and IRGP is not indicated. Reprinted from from Katritsis DG et al. Rapid pulmonary vein isolation combined with autonomic ganglia modification: a randomized study. Heart Rhythm. 2011;8:672-8. Copyright (2011), with permission from Elsevier.
Techniques of GP ablation
In the electrophysiology laboratory and the operating theater, identification of major GP has been mainly accomplished through high-frequency stimulation (HFS) and induction of vagal responses in the atria.[19,20] HFS is delivered at 1,200 bpm (20 Hz) with a pulse width of 10 ms at 12-24 V. A predominant efferent vagal response is defined as induction of AV block (> 2 sec) and hypotension or prolongation of the R-R interval by >50% during AF, following a 5-second application of high-frequency stimulation. During these studies the anatomic locations of these plexi in the human have been well characterized. However, the method usually entails the discomfort of general anaesthesia, since conscious patients may not tolerate more than 15 V. Furthermore, we have recently shown that that anatomic ablation, ie targeting the areas known to host GP in the left atrium (Figure 1) without previous identification of GP, yields superior clinical results than HFS-identification and ablation of GP in patients with paroxysmal AF.
Ablation in the Electrophysiology Laboratory
Isolated GP ablation has been employed for both paroxysmal and persistent AF with variable success. In paroxysmal AF, arrhythmia-free survival within the first year after the procedure ranged between 26 to 77%.[22-26] Success rates of <40% have been reported for persistent AF after a single procedure. GP ablation in combination with pulmonary vein (PV) isolation has yielded better results than PV isolation alone with reported success rates up to 80%.[4,26,28-30] We have conducted the only randomized study that has compared the efficacy of PV isolation vs PV isolation+GP ablation in 67 patients with paroxysmal AF. Recurrence of arrhythmia was documented in 18 (54.5%) patients in the PV group 4.7 ± 1.0 months after ablation, and repeat PV isolation was performed in 7 (21.2%) of these patients 5.1 ± 1.1 months after the first procedure. Recurrence of arrhythmia was documented in 9 (26.5%) patients in the GP+PV group 5.0 ± 1.3 months after ablation, and repeat ablation was performed in 6 (17.6%) of these patients 4.3 ± 0.5 months after the first procedure. At the end of follow-up, 20 (60.6%) patients in the PV group and 29 (85.3%) patients in the GP+PV group remained arrhythmia-free (log rank test, P = 0.019).
Addition of GP ablation to the conventional Maze procedure has produced improved outcomes with success rates 83-93% over the following year.[31-33] Although this approach is interesting it is associated by the risks of open heart surgery and the Maze which nowadays is only considered in patients subjected to valve surgery.
Thoracoscopic approaches combine PV isolation with selective GP ablation, with or without ligament of Marshall ablation or left atrial appendage amputation.[34-38] The reported success rates over one year follow-up range from 65 to 86%, and the procedure does not appear to have any associated mortality, with pleural effusion, pneumothorax, hemothorax, and phrenic nerve injury the reported complications so far.
Complications of GP ablation
Ablation-induced atrial or ventricular proarrhythmia has been reported with both endocardial and epicardial (thoracoscopic) approaches.[28,39-40] Anatomic GP modification appears to carry a higher risk of iatrogenic left atrial tachycardias than PV isolation. In our experience, anatomic or HFS-mediated GP ablation is complicated by atrial macroreentry in 2-10% of patients treated, but does not always require a repeat procedure, since these tachycardias may spontaneously resolve with time.[22,25,27,29]
GP ablation appears to be a safe and efficacious method to improve PV isolation in patients with AF, and has been used in the electrophysiology laboratory, and during the maze procedure or thoracoscopic approaches. However experience is limited and mainly based in patients with paroxysmal AF. Furthermore, the long-term efficacy is not known, and this is particularly important since restoration of autonomic activity may occur as early as 4 weeks following ablation. Controlled, randomized studies and more clinical experience are needed to accurately assess the clinical usefulness of this promising technique.
1. Liu L, Nattel S. Differing sympathetic and vagal effects on atrial fibrillation in dogs: role of refractoriness heterogeneity. Am J Physiol. 1997;273:H805-16.
2. Chiou CW, Eble JN, Zipes DP. Efferent vagal innervation of the canine atria and sinus and atrioventricular nodes. The third fat pad. Circulation. 1997;95:2573–2584.
3. Bettoni M, Zimmermann M. Autonomic tone variations before the onset of paroxysmal atrial fibrillation. Circulation. 2002;105:2753–2759.
4. Scherlag BJ, Nakagawa H, Jackman WM, Yamanashi WS, Patterson E, Po S, Lazzara R. Electrical stimulation to identify neural elements on the heart: their role in atrial fibrillation. J Interv Card Electrophysiol. 2005;13 Suppl 1:37-42.
5. Nakagawa H, Jackman WM, Scherlag BJ, Lazzara R. Pulmonary vein isolation during atrial fibrillation: insight into the mechanism of pulmonary vein firing. J Cardiovasc Electrophysiol. 2003;14:261-272.
6. Pappone C, Santinelli V, Manguso F, Vicedomini G, Gugliotta F, Augello G, Mazzone P, Tortoriello V, Landoni G, Zangrillo A, Lang C, Tomita T, Mesas C, Mastella E, Alfieri O.Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. Circulation. 2004;109:327-34.
7. Scanavacca M, Pisani CF, Hachul D, Lara S, Hardy C, Darrieux F, Trombetta I, Negrão CE, Sosa E. Selective atrial vagal denervation guided by evoked vagal reflex to treat patients with paroxysmal atrial fibrillation. Circulation. 2006;114:876-85.
8. Schauerte P, Scherlag BJ, Pitha J, Scherlag MA, Reynolds D, Lazzara R, Jackman WM. Catheter ablation of cardiac autonomic nerves for prevention of vagal atrial fibrillation. Circulation. 2000;102:2774-80.
9. Oh S, Zhang Y, Bibevski S, Marrouche NF, Natale A, Mazgalev TN. Vagal denervation and atrial fibrillation inducibility: epicardial fat pad ablation does not have long-term effects. Heart Rhythm. 2006; 3:701-8.
10. Hirose M, Leatmanoratn Z, Laurita KR, Carlson MD. Partial vagal denervation increases vulnerability to vagally induced atrial fibrillation. J Cardiovasc Electrophysiol. 2002;13:1272-9.
11. Cummings JE, Gill I, Akhrass R, Dery M, Biblo LA, Quan KJ. Preservation of the anterior fat pad paradoxically decreases the incidence of postoperative atrial fibrillation in humans. J Am Coll Cardiol. 2004;43:994–1000.
12. Hwang C, Karagueuzian HS, Chen PS. Idiopathic paroxysmal atrial fibrillation induced by a focal discharge mechanism in the left superior pulmonary vein. Possible role of the ligament of Marshall. J Cardiovasc Electrophysiol 1999: 10: 636-648.
13. Doshi RN, Wu TJ, Yashima M, Kim YH, Ong JJC, Cao JM, Hwang C, Yashar P, Fishbein MC, Karagueuzian HS, Chen P-S. Relation between ligament of Marshall and adrenergic atrial tachyarrhythmia. Circulation 1999: 100: 876-883.
14. Hwang C, Wu TJ, Doshi RN, Peter CT, Chen PS. Vein of Marshall cannulation for the analysis of electrical activity in patients with focal AF. Circulation 2000; 101:1503-1505.
15. Katritsis D, Ioannidis JP, Anagnostopoulos CE, Sarris GE, Giazitzoglou E, Korovesis S, Camm AJ. Identification and catheter ablation of extracardiac and intracardiac components of ligament of Marshall tissue for treatment of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol. 2001;12:750-8.
16. Armour JA, Murphy DA, Yuan BX, Macdonald S, Hopkins DA. Gross and microscopic anatomy of the human intrinsic cardiac nervous system. Anat Rec. 1997;247:289-98.
17. Kawashima T. The autonomic nervous system of the human heart with special reference to its origin, course, and peripheral distribution. Anat Embryol (Berl). 2005;209:425-38.
18. Ulphani JS, Arora R, Cain JH, Villuendas R, Shen S, Gordon D, Inderyas F, Harvey LA, Morris A, Goldberger JJ, Kadish AH. The ligament of Marshall as a parasympathetic conduit. Am J Physiol Heart Circ Physiol. 2007;293:H1629-35.
19. Lemery R, Birnie D, Tang AS, Green M, Gollob M. Feasibility study of endocardial mapping of ganglionated plexuses during catheter ablation of atrial fibrillation. Heart Rhythm. 2006;3:387-96.
20. Mehall JR, Kohut RM Jr, Schneeberger EW, Taketani T, Merrill WH, Wolf RK. Intraoperative epicardial electrophysiologic mapping and isolation of autonomic ganglionic plexi. Ann Thorac Surg. 2007;83:538-41.
21. Lemery R. How to perform ablation of parasympathetic ganglia of the left atrium. Heart Rhythm 2006;3: 1237-1239.
22. Pokushalov E, Romanov A, Shugayev P, Artyomenko S, Shirokova N, Turov A, Katritsis DG. Selective ganglionated plexi ablation for paroxysmal atrial fibrillation. Heart Rhythm. 2009;6:1257-64.
23. Danik S, Neuzil P, d'Avila A, Malchano ZJ, Kralovec S, Ruskin JN, Reddy VY. Evaluation of catheter ablation of periatrial ganglionic plexi in patients with atrial fibrillation. Am J Cardiol. 2008;102:578-83.
24. Katritsis D, Giazitzoglou E, Sougiannis D, Goumas N, Paxinos G, Camm AJ. Anatomic approach for ganglionic plexi ablation in patients with paroxysmal atrial fibrillation. Am J Cardiol. 2008;102:330-4.
25. Pokushalov E, Romanov A, Artyomenko S, Turov A, Shirokova N, Katritsis DG. Left Atrial Ablation at the Anatomic Areas of Ganglionated Plexi for Paroxysmal Atrial Fibrillation. Pacing Clin Electrophysiol. 2010;33:1231-8.
26. Mikhaylov E, Kanidieva A, Sviridova N, Abramov M, Gureev S, Szili-Torok T, Lebedev D.
Outcome of anatomic ganglionated plexi ablation to treat paroxysmal atrial fibrillation: a 3-year follow-up study. Europace. 2011;13:362-70.
27. Pokushalov E, Romanov A, Artyomenko S, et al. Ganglionated plexi ablation for longstanding persistent atrial fibrillation. Europace. 2010;12:342-6.
28. Po SS, Nakagawa H, Jackman WM. Localization of Left Atrial Ganglionated Plexi in Patients with Atrial Fibrillation. J Cardiovasc Electrophysiol. 2009;20:1186-9.
29. Katritsis DG, Giazitzoglou E, Zografos T, Pokushalov E, Po SS, Camm AJ. Rapid pulmonary vein isolation combined with autonomic ganglia modification: a randomized study. Heart Rhythm. 2011;8:672-8.
30. Zhou Q, Hou Y, Yang S. A Meta-Analysis of the Comparative Efficacy of Ablation for Atrial Fibrillation with and without Ablation of the Ganglionated Plexi. Pacing Clin Electrophysiol. 2011 Sep 28. [Epub ahead of print]
31. Doll N, Pritzwald-Stegmann P, Czesla M, et al. Ablation of ganglionic plexi during combined surgery for atrial fibrillation. Ann Thorac Surg. 2008;86:1659-63.
32. Ware AL, Suri RM, Stulak JM, Sundt TM 3rd, Schaff HV. Left atrial ganglion ablation as an adjunct to atrial fibrillation surgery in valvular heart disease. Ann Thorac Surg. 2011;91:97-102.
33. Onorati F, Curcio A, Santarpino G, Torella D, Mastroroberto P, Tucci L, Indolfi C, Renzulli A. Routine ganglionic plexi ablation during Maze procedure improves hospital and early follow-up results of mitral surgery. J Thorac Cardiovasc Surg. 2008;136:408-18.
34. McClelland JH, Duke D, Reddy R. Preliminary results of a limited thoracotomy: new approach to treat atrial fibrillation. J Cardiovasc Electrophysiol. 2007;18:1289-95.
35. Han FT, Kasirajan V, Kowalski M, Kiser R, Wolfe L, Kalahasty G, Shepard RK, Wood MA, Ellenbogen KA. Results of a minimally invasive surgical pulmonary vein isolation and ganglionic plexi ablation for atrial fibrillation: single-center experience with 12-month follow-up. Circ Arrhythm Electrophysiol. 2009;2:370-7.
36. Yilmaz A, Geuzebroek GS, Van Putte BP, et al. Completely thoracoscopic pulmonary vein isolation with ganglionic plexus ablation and left atrial appendage amputation for treatment of atrial fibrillation. Eur J Cardiothorac Surg. 2010;38:356-60.
37. Edgerton JR, Brinkman WT, Weaver T, et al. Pulmonary vein isolation and autonomic denervation for the management of paroxysmal atrial fibrillation by a minimally invasive surgical approach. J Thorac Cardiovasc Surg. 2010;140:823-8.
38. Krul SP, Driessen AH, van Boven WJ, Linnenbank AC, Geuzebroek GS, Jackman WM, Wilde AA, de Bakker JM, de Groot JR. Thoracoscopic video-assisted pulmonary vein antrum isolation, ganglionated plexus ablation, and periprocedural confirmation of ablation lesions: first results of a hybrid surgical-electrophysiological approach for atrial fibrillation. Circ Arrhythm Electrophysiol. 2011;4:262-70.
39. Kron J, Kasirajan V, Wood MA, Kowalski M, Han FT, Ellenbogen KA. Management of recurrent atrial arrhythmias after minimally invasive surgical pulmonary vein isolation and ganglionic plexi ablation for atrial fibrillation. Heart Rhythm. 2010;7:445-51.
40. Osman F, Kundu S, Tuan J, Jeilan M, Stafford PJ, Andre Ng G. Ganglionic plexus ablation during pulmonary vein isolation - predisposing to ventricular arrhythmias? Indian Pacing Electrophysiol J. 2010;10:104-7.
41. Sakamoto S, Schuessler RB, Lee AM, Aziz A, Lall SC, Damiano RJ Jr. Vagal denervation and reinnervation after ablation of ganglionated plexi. J Thorac Cardiovasc Surg. 2010;139:444-52.